Simplification of a suppressive triple antiretroviral therapy to a dual or monotherapy has demonstrated safety and efficacy in a high proportion of stable patients. The key rationales behind regimen simplification are to improve the patient's quality of life and to maintain long-term compliance, without enhancing the risk of virological failure. A simplified startegy offers the potential advantages of a decreased risk of toxicities associated with the use of nucleoside analogue reverse transcriptase inhibitors. Moreover, the use of high genetic barrier antiretroviral drugs (basically, PIs/r) in dual regimen or in monotherapy regimen minimises the selection of drug-resistant HIV variants. The aim of this paper is to present a score that taking into account all the data in the literature relating to the simplification studies to monotherapy with PI/r allows the clinician to have more information to choose with less chance of error by the patient simplify.

Andreoni, M. (2014). [Simplification of antiretroviral therapy: proposal for a score for the evaluation of patients with suppressed viremia]. RECENTI PROGRESSI IN MEDICINA, 105(12), 462-8 [10.1701/1706.18618].

[Simplification of antiretroviral therapy: proposal for a score for the evaluation of patients with suppressed viremia]

ANDREONI, MASSIMO
2014-12-01

Abstract

Simplification of a suppressive triple antiretroviral therapy to a dual or monotherapy has demonstrated safety and efficacy in a high proportion of stable patients. The key rationales behind regimen simplification are to improve the patient's quality of life and to maintain long-term compliance, without enhancing the risk of virological failure. A simplified startegy offers the potential advantages of a decreased risk of toxicities associated with the use of nucleoside analogue reverse transcriptase inhibitors. Moreover, the use of high genetic barrier antiretroviral drugs (basically, PIs/r) in dual regimen or in monotherapy regimen minimises the selection of drug-resistant HIV variants. The aim of this paper is to present a score that taking into account all the data in the literature relating to the simplification studies to monotherapy with PI/r allows the clinician to have more information to choose with less chance of error by the patient simplify.
dic-2014
Pubblicato
Rilevanza nazionale
Articolo
Esperti anonimi
Settore MED/17 - MALATTIE INFETTIVE
Italian
Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Resistance, Viral; Drug Therapy, Combination; HIV Infections; Humans; Medication Adherence; Quality of Life; Viremia
Andreoni, M. (2014). [Simplification of antiretroviral therapy: proposal for a score for the evaluation of patients with suppressed viremia]. RECENTI PROGRESSI IN MEDICINA, 105(12), 462-8 [10.1701/1706.18618].
Andreoni, M
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/186939
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact